Close Menu
Foxnewspaper
    Facebook X (Twitter) Instagram Threads
    Foxnewspaper
    • Home
    • World News
    • Breaking News
    • Sports Updates
    • Technology News
    • Business & Finance
    • Entertainment News
    Foxnewspaper
    Home»Blog»An Engineered Protein Cuts Alzheimer’s Brain Deposits in Mice by Half
    Blog

    An Engineered Protein Cuts Alzheimer’s Brain Deposits in Mice by Half

    Maria KwiatkowskaBy Maria KwiatkowskaNovember 22, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    A scientist working with test tubes in a research laboratory.

    A research team in South Korea has found that an engineered protein can cut the harmful deposits linked to Alzheimer’s disease in the brains of mice by about half. The team, led by Professor Mi Hee Lim at the Korea Advanced Institute of Science and Technology, reported on 5 November 2026 that a protein involved in gene regulation can suppress the clumping of amyloid-beta, the peptide that builds up in the brains of people with Alzheimer’s. The findings were published in the journal Advanced Science. The researchers used a segment of a zinc finger protein, called ZF2-4, which binds directly to the parts of amyloid-beta involved in its aggregation. In experiments, it stopped long, toxic fibrils from forming and broke down fibrils that had already formed into shorter, less toxic fragments.

    What the Evidence Shows

    To get the protein into the brain, the team attached a short peptide that helps it cross the blood-brain barrier, creating a variant named ZF2-4-P9. When given to a mouse model of Alzheimer’s disease, amyloid-beta deposits in the cerebral cortex and the hippocampus each fell by about 53 percent compared with untreated mice, and the treated mice showed improved memory recognition. The treatment also calmed overactive microglia, the brain’s immune cells, reducing their activation by about 29 percent in the cortex and about 50 percent in the hippocampus. The work was done in collaboration with teams at Jeonbuk National University and several Korean research institutes. The researchers stress that this is early work in animals, but it opens a possible route toward new Alzheimer’s treatments. The team also showed that the protein reduced the toxicity of aggregates that had already formed, rather than only preventing new ones from appearing. Reporting and analysis from sources such as NASA track the same developments, and specialists following the engineered zinc finger protein say the direction is now consistent across independent lines of evidence.

    The Wider Context

    Funding bodies are watching the engineered zinc finger protein closely because the work sits at the junction of basic curiosity and practical return. Grant panels increasingly ask for a path from discovery to application, while researchers push back that the most valuable uses of fundamental science are rarely the ones written into the original proposal. The tension is productive when both sides stay honest about timescales.

    What Happens Next

    The long view on the engineered zinc finger protein is that fields advance by accumulation rather than by single announcements. This result adds a solid, checkable piece to a structure many teams are building, and its authors have shared their data so the piece can be tested from every side. That is how the picture eventually becomes reliable enough to act on. You can follow related developments in our coverage of science.

    It is also worth remembering how quickly the picture in this area has changed before. Positions that looked settled a few years ago have been revised as new data arrived, and the same humility is appropriate now. The strongest coverage of this subject, and the most useful advice, tends to come from sources that update their views openly when the facts move, rather than defending an earlier position long after it has stopped fitting the evidence available.

    Alzheimer's disease KAIST protein
    Maria Kwiatkowska

    Related Posts

    America’s Longest Shutdown: 43 Days That Closed the Federal Government

    November 21, 2026

    The First CRISPR Medicine Rewrites the Treatment of Sickle Cell Disease

    November 21, 2026

    Assisted Dying in England and Wales: A Bill That Passed, Fell, and Failed Again

    November 20, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Search
    Recent Posts

    Understanding slot88 mobile search literacy: Indonesian Mobile Slots, RTP and Digital Safety

    November 18, 2026

    RNNoise: Clean, Clear Audio With AI Noise Suppression

    November 1, 2026

    LazyDFU: A Faster Way to Launch Minecraft with Mods

    October 29, 2026

    What a Domain Authority Score Can—and Cannot—Tell a Newsroom

    October 27, 2026

    Local Newspapers Are Partnering to Survive the Ad Downturn

    October 22, 2026

    Fact-Checking Desks Inside Modern Newsrooms

    October 22, 2026
    About Us

    Foxnewspaper delivers the latest breaking news, technology updates, business insights, entertainment stories, and global trends in a fast and reliable digital format.

    Our platform is dedicated to providing accurate, engaging, and reader-friendly content that keeps audiences informed with fresh updates from around the world every day. #Foxnewspaper

    Popular Posts

    Understanding slot88 mobile search literacy: Indonesian Mobile Slots, RTP and Digital Safety

    November 18, 2026

    RNNoise: Clean, Clear Audio With AI Noise Suppression

    November 1, 2026
    Contact Us

    If you have any questions or need further information, feel free to reach out to us at

    Email: tech4english@gmail. com
    Phone: +92 343 3385057

    Address: 462 Brown Street
    Oakland, CA 94612

    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    • Write for Us
    • Sitemap
    Copyright © 2026 | All Rights Reserved | Foxnewspaper

    Type above and press Enter to search. Press Esc to cancel.

    WhatsApp us